Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
TELO | Telomir Pharmaceuticals, Inc. | Chief Financial Officer | $151K | Aug 27, 2024 | ||
INTI | Inhibitor Therapeutics, Inc. | Director | Dec 31, 2024 | |||
MIRA | MIRA PHARMACEUTICALS, INC. | Chief Financial Officer | Dec 9, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|